# Type 1 Diabetes and LADA

> Type 1 diabetes and LADA for NEET-PG Medicine covers beta cell destruction, islet autoantibodies, the honeymoon phase and adult latent autoimmune diabetes.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/type-1-diabetes-and-lada
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: Williams Textbook of Endocrinology; Harrison's Principles of Internal Medicine
- How to cite: "Type 1 Diabetes and LADA", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/type-1-diabetes-and-lada

## Direct answer

Type 1 diabetes is an autoimmune disease in which T cells destroy pancreatic beta cells, leaving the patient absolutely insulin deficient and prone to ketoacidosis. Latent autoimmune diabetes in adults, or LADA, is a slower form that presents in adulthood, initially looks like type 2 diabetes, and is confirmed by GAD65 antibodies.

## What you must remember

- **Mechanism:** progressive T cell-mediated destruction of beta cells, with HLA DR3 and DR4 genotypes carrying the strongest genetic risk.
- **Autoantibodies:** GAD65, IA-2, ZnT8 and insulin autoantibodies mark autoimmunity and help predict progression.
- **Honeymoon phase:** a temporary remission after diagnosis, with falling insulin needs while residual beta cell function lasts.
- **C-peptide:** low or undetectable C-peptide reflects absolute insulin deficiency and separates type 1 from type 2 diabetes.
- **LADA:** adult onset, usually after age 30, GAD65 positive, initially not insulin requiring and progressing to insulin dependence over months to years.
- **Associations:** Hashimoto thyroiditis, Graves disease, Addison disease, coeliac disease and vitiligo, which link to polyglandular autoimmunity.
- **Treatment:** insulin is the durable therapy in both forms, while oral agents are less effective as the disease advances.

## Separating type 1, LADA and type 2 at the bedside

Students lose marks by treating every adult with diabetes as type 2 without checking antibodies. The table compares the three presentations on the features examiners test most often.

| Feature | Type 1 diabetes | LADA | Type 2 diabetes |
|---|---|---|---|
| Typical onset | Childhood to young adult | Adults, usually after age 30 | Adults, increasingly younger |
| Body habitus | Often lean | Often lean or normal weight | Often obese |
| Antibodies | GAD65, IA-2 and ZnT8 frequently positive | GAD65 positive | Usually negative |
| C-peptide | Low or absent early | Falls over time | Often preserved initially |
| Insulin need | Immediate, often with ketosis | Delayed, over months to years | Often much later |

A lean adult with positive GAD65 antibodies who is not yet on insulin has LADA rather than early type 2 diabetes, and needs monitoring for progression. Antibody status and serial C-peptide values guide the timing of insulin. Because beta cell reserve falls over time, these values are rechecked at follow-up rather than read once at diagnosis.

## High-yield viva angles

Examiners test the age cut-off and the true meaning of remission.

- **Trap:** Assuming honeymoon remission means the disease has resolved. — **Correct:** Beta cell function declines afterwards, so insulin dosing must be reviewed and insulin is never safely stopped.
- **Trap:** Using a sulfonylurea as long-term therapy in LADA on type 2 reasoning. — **Correct:** LADA progresses to insulin dependence, so insulin is the durable treatment.
- **Trap:** Ruling out autoimmune diabetes because the patient is an adult. — **Correct:** LADA is an adult form, so GAD65 antibodies must be measured in lean adults with diabetes.

## Frequently asked questions

### Which antibody confirms latent autoimmune diabetes in adults?

GAD65 antibody is the antibody most commonly used to confirm latent autoimmune diabetes in adults. Its positivity in an adult who is not yet insulin dependent separates LADA from type 2 diabetes.

### What is the honeymoon phase in type 1 diabetes?

The honeymoon phase is a temporary period after diagnosis when residual beta cell function lowers the insulin requirement. It lasts a variable period, often months, and insulin needs rise again as beta cell function declines, so it is not a cure.

### Why does LADA respond poorly to oral antidiabetic drugs over time?

Autoimmune destruction of beta cells in LADA progresses, so the residual insulin secretion that oral agents depend on falls. Insulin therapy then becomes necessary, because sulfonylureas and other oral drugs lose effect as the disease advances.

### Which antibodies are measured in new-onset type 1 diabetes?

GAD65, IA-2, ZnT8 and insulin autoantibodies are measured in new-onset type 1 diabetes, with islet cell antibodies used in some settings. Positivity confirms autoimmunity, and the number of positive antibodies helps predict progression in at-risk relatives.